Skip to main content

Table 1 Clinicopathological characteristics and BMP-2 mRNA expression in NSCLC patients (N = 61)

From: Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration

Parameter n Expression level P-value
Sex    0.415
 Male 29 0.8383 ± 0.13541
 Female 32 0.8692 ± 0.15649
Age (years)    0.312
 ≥60 33 0.8369 ± 0.12853
 <60 28 0.8753 ± 0.16512
Differentiation    
 Well 19 0.8704 ± 0.15222 0.573
 Moderate-poor 42 0.8473 ± 0.14509  
Tumor stage    0.014*
 T1 18 0.8260 ± 0.13904
 T2 31 0.8290 ± 0.14797
 T3–4 12 0.9632 ± 0.1066
TNM stage    0.341
 I 26 0.8356 ± 0.13043
 II 22 0.8458 ± 0.17847
 III 13 0.9071 ± 0.11028
Nodal status    0.026*
 Positive 28 0.8994 ± 0.15196
 Negative 33 0.8164 ± 0.13218
  1. *Indicates statistical significance (P < 0.05).